Sign In
Get Clay Free →

Suggestions

    Alan Roth

    Chief Executive Officer at Oxford Drug Design

    Alan D. Roth is the Chief Executive Officer at Oxford Drug Design, a position he has held since November 2020.3 He is an experienced professional in the life sciences industry with a background in chemistry, business, and entrepreneurship.

    Dr. Roth holds a BA in Chemistry from Cornell University, a PhD from Columbia University, and completed a postdoctoral fellowship in medicinal chemistry at the University of Oxford.13 His career spans various roles in academia, industry, and entrepreneurship:

    1. He started as a chemist at Merck & Co., Inc. in New Lead Discovery.1
    2. He worked as a Senior Associate at McKinsey & Company from 1992 to 1994.3
    3. He served as Director at Commerzbank Asset Management from 1997 to 2002, overseeing global equity bio-investments.13
    4. In 2002, he co-founded Chiral Quest, Inc., a life sciences company, and served as its first CEO and CFO.13
    5. Since 2006, he has been the Managing Director of Fitzroy Partners Limited, developing ventures in health sciences.3

    At Oxford Drug Design, Dr. Roth focuses on expanding the drug discovery portfolio and strengthening their AI-tRNA synthetases platform to develop innovative cancer therapeutics.3 He is also a Royal Society Entrepreneur in Residence and a Visiting Lecturer at the University of Oxford, teaching a course on Scientific Entrepreneurship.23

    Dr. Roth is multilingual, with proficiency in French, Italian, Spanish, German, and English.3 His expertise spans organic and physical chemistry, drug discovery, business strategy, and entrepreneurship in the life sciences sector.

    Highlights

    Dec 9 · winston.com
    Alan Roth - Winston & Strawn
    Jan 1 · mpls.ox.ac.uk
    Dr Alan Roth - Mathematical, Physical and Life Sciences Division

    Related Questions

    What is Alan Roth's background before becoming CEO of Oxford Drug Design?
    How does Alan Roth's role as Royal Society Entrepreneur in Residence impact his work at Oxford Drug Design?
    What are the main goals of Oxford Drug Design under Alan Roth's leadership?
    How does Alan Roth's experience in private equity influence his approach at Oxford Drug Design?
    What is the significance of the AI drug discovery platform SynthAI developed by Oxford Drug Design?
    Alan Roth
    Alan Roth, photo 1
    Alan Roth, photo 2
    Add to my network

    Location

    United Kingdom